This issue of Hematology/Oncology Clinics, guest edited by Dr. F. Stephen Hodi, is devoted to Melanoma. Articles in this issue include: The current state of Melanoma; Understanding the Biology of Melanoma Development and Therapeutic Implications; Surgical Management of Melanoma; Targeted Therapies for Cutaneous Melanoma; Treatments for Non-cutaneous Melanoma; Resistant Mechanisms and Therapeutic Implications; The Role of the Immune System in Melanoma Development and Treatment; Vaccines and Melanoma; IL-2, Interferon, and Cytokines; Immune Checkpoint Blockade; Adjuvant Treatments, Chance for Cure in Melanoma; and Combinatorial Approach to Treatment of Melanoma.
This issue of Hematology/Oncology Clinics, Guest Edited by F. Stephen Hodi, is devoted to Melanoma. This issue is one of six selected each year by our series Consulting Editors, George P. Canellos and Edward J. Benz.
Therapeutic vaccines and immunotherapy in castration-resistant prostate cancer: current progress and clinical applications. Am Soc Clin Oncol Educ Book 2013. https://doi.org/10.1200/EdBook_AM.2013. 33.e166. 42. Stein WD, Gulley JL, ...
27. Morrison AO, Gardner JM, Goldsmith SM, et al. Primary Malignant Sweat Gland Tumors 69.
This issue of Hematology/Oncology Clinics, guest edited by Dr. Glenn J. Hanna, will focus on Head and Neck Cancer. This issue is one of six selected each year by our series consulting editors, Dr. George P. Canellos and Dr. Edward J. Benz.
Topics include: Rare Cancers; Mast Cell Leukemia; Uveal Melanoma; Esthesioneuroblastoma; Parathyroid Carcinoma; Thymoma/Thymic Carcinoma; Mesothelioma; Gastrointestinal Stromal Tumor (GIST); Uterine Sarcoma; Cancer of the Appendix; Urethral ...
metastasis has been made due to costs associated with treatment and hospitalization.4 Advances in early cancer detection and improvements in therapeutic care to patients with systemic cancers are expected to result in reduced metastases ...
The field of melanoma biology has experienced a remarkable surge in recent years, owing to progress which has ranged from the most basic laboratory/preclinical discoveries to clinical developments that have begun to transform the management ...
BRCA1 and BRCA2 mutations increase the risk of breast and ovarian cancer, fallopian tube cancer, male breast cancer, and prostate cancer. Furthermore, BRCA2 mutations are associated with PDAC and melanoma risk, whereas those ...
Guest Editor Brian Wolpin, MD has assembled a group of expert authors to review the following topics: Biology and genetics of pancreatic adenocarcinoma; Mouse models of pancreatic adenocarcinoma; Epidemiology and inherited predisposition ...
xii Systemic Amyloidosis due to Monoclonal Immunoglobulins HEMATOLOGY/ONCOLOGY CLINICS OF NORTH AMERICA SERIES OF RELATED ... FORTHCOMING ISSUES RECENT ISSUES February 2021 Melanoma F. Stephen Hodi, Editor April 2021 Myeloproliferative ...